Articles tagged with Neuromodulation
Researchers propose a new standard, Human Fidelity, to measure the alignment of implantable brain devices with stakeholders' needs and expectations. The study identified five domains where gaps between devices and stakeholders exist, including Access and Uptake, Invasiveness, and Patient-Centered Outcomes.
Researchers identified disrupted neural circuits behind Huntington's disease and used optogenetics to selectively activate key neurons, restoring function and improving motor skills. The study provides hope for future therapies targeting specific brain circuit imbalances.
Researchers propose a unifying framework to rebuild brain–spinal communication in SCI patients, enabling closed-loop neurotechnology to support stable or adaptive function. The study introduces three technological routes to address communication loss, state mismatch, and learning failure.
Gonçalo Cotovio uses lesion network mapping to identify the circuits responsible for psychiatric symptoms, aiming to develop personalized brain stimulation treatments. His work has produced striking findings in mania and obsessive-compulsive disorder, with ambitions to extend to disordered feeding behavior.
Genomic Press launches Brain Health, a new peer-reviewed journal dedicated to the science of lifelong brain resilience, featuring research on glial plasticity and recovery from depression. The inaugural issue explores the intersection of fields including cognitive reserve, sleep, aging biology, nutritional psychiatry, and social sciences.
Motif Neurotech has received FDA approval to begin the first clinical trial of its therapeutic BCI device, DOT, for treatment-resistant depression. The study will test the device's effectiveness in delivering electrical stimulation to brain circuits linked to depression.
A new study reveals that electroconvulsive therapy (ECT) can lead to significant negative impacts on standard of living, personal relationships, and even brain damage. Relatives and friends of ECT patients report long-term effects including memory loss, emotional blunting, and loss of independence.
A Korean research team developed a spinal cord stimulator that softens upon contact with bodily fluids, mimicking surrounding nerve tissue. The device uses liquid metal and variable stiffness structures to achieve stable signal transmission and reduced costs.
Researchers have identified a distinct gene expression program associated with neurotransmission in the living human brain. The study combines molecular data with real-time physiological recordings, revealing a coordinated set of genes whose activity tracks with neuronal signaling.
A new study found that transcranial direct current stimulation (tDCS) can enhance task engagement and activation of brain regions associated with executive function in individuals with comorbid anxiety and depression. However, it unexpectedly heightened sensitivity to threats, including increased eyeblink startle response under conditi...
Researchers developed a soft, wireless implant that modulates the splenic nerve to restore immune balance in patients with chronic inflammatory diseases. The device showed excellent biocompatibility and reduced inflammation in a rat model of chronic colitis.
Researchers propose a closed-loop system combining peripheral nerve stimulation (PNS) with brain-computer interfaces (BCIs) to personalize neuromodulation. This approach aims to address treatment-resistant depression and schizophrenia by dynamically tailoring interventions to individual neural signatures.
A nonsurgical approach has been demonstrated to quiet a specific brain circuit in an animal model by delivering engineered gene therapy only to the targeted region. The method uses low-intensity focused ultrasound to open the blood-brain barrier, allowing precise control over brain activity without impacting off-target areas.
A team of researchers from Rice University and the Houston Methodist Research Institute will study how the brain responds to neural implants. They aim to develop more stable and longer-lasting brain-computer interfaces and neuroprosthetics, which could treat neurological disorders such as Parkinson’s disease, epilepsy, and stroke.
Researchers at Washington University in St. Louis have developed a new fiber-optic device, PRIME, which delivers multi-site, reconfigurable optical stimulation through a single implant. This technology enables manipulation of neural activity deep in the brain and holds promise for understanding complex brain circuits.
Scientists have developed ingestible devices that deliver targeted light stimulation directly to the gut, allowing researchers to precisely illuminate specific nerve cells. This technology could reveal new targets for treating conditions like gastroparesis and metabolic diseases.
Researchers found that astrocytes maintain optimal levels of GABA to enable neural groups to process visual information efficiently. Knocking out Gat3 in mice impaired neuron coordination and reduced ensemble activity, highlighting the importance of astrocytic regulation.
Researchers have successfully controlled a dexterous robotic hand using noninvasive EEG-based Brain-Computer Interfaces (BCIs) for individual finger movements. The study demonstrates real-time brain decoding and motor imagery control, paving the way for potential applications beyond basic communication to intricate motor control.
A new brain training game has shown promise in treating nerve pain, with participants experiencing significant reductions in pain and comparable relief to opioids. The PainWaive technology uses EEG headsets to track brain activity and respond in real time, providing a potential non-invasive alternative for chronic pain management.
Astrocytes, once thought to be supporting cells, are active players in neuromodulation, controlling neuronal activity and behavior. The discovery of a biochemical circuit involving ATP and adenosine reveals a slower time scale for modulation compared to neural circuits.
A new technique using focused sound waves and microbubbles has shown great promise in treating debilitating brain lesions called cerebral cavernous malformations. The approach has halted the growth of lesions almost entirely, offering a potential paradigm shift in treatment.
A clinical study found that patients with PTSD showed significant symptom-free periods up to six months after receiving vagus nerve stimulation paired with traditional therapy. The results highlight the potential of this approach in treating treatment-resistant PTSD.
Researchers found that immune molecule IL-17 influences brain regions to induce either anxiety in the amygdala or sociable behavior in the somatosensory cortex. This discovery highlights the interconnectedness of the immune and nervous systems.
Researchers have identified three cell types in the median raphe nucleus that control decisions on perseverance, exploration, and disengagement. These findings may help understand neuropsychiatric conditions such as OCD, autism, and major depressive disorder.
A new survey found that patients with neurological and mental health disorders prefer non-invasive neuromodulation interventions over current medications. The study, published in Scientific Reports, suggests that providing accurate information to patients improves their perception of these treatments.
A study by TU Wien found that nerve stimulation is more effective when synchronized with the body's natural rhythms, particularly during systole and inspiration. This technology has potential for non-invasive treatment of chronic diseases.
The Advanced Research + Invention Agency has awarded $84.2 million to Rice researchers to explore and unlock new methods for interfacing with the human brain at the circuit level. The project involves developing a distributed network of minimally invasive implants to stimulate neural circuits with cell-type precision.
A research group at the University of Tsukuba discovered that the dorsal premotor cortex plays a crucial role in meta-learning for motor skills. The study found that stimulating this region impairs the meta-learning effect on memory forgetting, but not motor learning itself.
Researchers developed an 8-channel neural stimulation chip with exponential waveform output, achieving 98% power efficiency and advanced charge-balancing capabilities. This breakthrough enhances neural modulation and brain-machine interface devices for safer treatments of neurological conditions.
Recent advances in Brain Network Models (BNMs) have improved simulations of brain activities, understanding neuropathological mechanisms, and predicting disease progression. BNMs integrate structural and functional connectivity data to analyze abnormal network dynamics.
A recent study found that tau protein buildup disrupts the salience network, a crucial communication network in the brain, leading to behavioral changes. The study used advanced medical imaging to analyze the brains of 128 people with early-stage dementia and showed a strong association between tau disruption and behavioral symptoms.
University of Rochester researchers have refined a noninvasive method called BL-OG that harnesses light to activate neurons in the brain. The technique has the potential to transform invasive procedures used to treat Parkinson's disease and other neurological conditions by providing a safer, less invasive alternative.
Researchers developed a shape-morphing cortex-adhesive sensor to monitor brain activity during tFUS stimulation, enabling real-time adjustments and suppressing seizures. The innovative device overcomes challenges in existing cortex-interfacing devices, providing stable and accurate monitoring.
Researchers at Duke University have developed a computer model that simulates nerve responses to electrical stimulation, enabling the efficient design of more effective and targeted neuromodulation therapies. The new tool, called S-MF, runs thousands of times faster than current industry standards without sacrificing accuracy or detail.
A team of researchers has developed light-activated compounds that can inhibit nerve signals locally and on demand, offering a potential treatment for neuropathic pain. The compounds, which are activated by amber-colored light, show photopharmacological activity in animal models.
Researchers at Carnegie Mellon University have successfully integrated focused ultrasound stimulation into noninvasive BCIs, significantly boosting signal quality and enabling bidirectional brain-computer interfaces. The technology allows individuals to control a cursor or robotic arm using only their thoughts.
Kessler Foundation and collaborators win $1 million prize for proof-of-concept study on tablet-type controller StimXS, designed to help individuals with spinal cord injuries manage autonomic functions. The team advances to Phase 3 of the NIH Common Fund's Neuromod Prize competition.
A new study by researchers at the University of Minnesota reveals that non-invasive brain stimulation can change a specific brain mechanism related to human behavior. The technique, called transcranial alternating current stimulation, modulates brain activity by shifting when brain cells are active.
Researchers discuss recent advances in brain mapping, emphasizing the need to establish precise neuromodulation paradigms based on individual characteristics. Individualized brain mapping methods have evolved from manual labeling to staining techniques across multiple subjects.
Researchers at Washington University in St. Louis used specially made nanostructures to enhance the locust's ability to detect odors, boosting neural signals for improved chemical sensing. The team created a biocompatible and biodegradable nanoparticle that converts light to heat, amplifying neural activity.
A recent study published in Cerebral Cortex found that participants exposed to 18-Hz beta binaural beats had significantly higher accuracy and faster response times during comprehension tasks. This suggests that binaural beat stimulation at this frequency may be a potential tool for improving language skills.
A growing number of studies have found that non-invasive sensory, electrical, or magnetic stimulation of gamma brain rhythms can reduce Alzheimer's pathology and its consequences. These studies have shown increases in gamma power, brain network connectivity, and improvements in memory, cognition, and sleep.
A new study from UCLA Health researchers demonstrates that repetitive transcranial magnetic stimulation (rTMS) is effective in most patients with major depressive symptoms, starting to alleviate symptoms as quickly as one week. The treatment was found to be associated with a significant response rate of 54% of patients, with early impr...
Scientists have developed a method for controlling brain activity in living organisms using infrared light-controlled drugs. The technique uses mid-infrared light to activate a specific neurotransmitter receptor, providing unparalleled precision in three dimensions.
Researchers at Sainsbury Wellcome Centre find frontal and parietal cortex play key role in encoding value of economic choices when faced with uncertainty. The study provides foundation for understanding neurobiology of risky decisions.
Researchers have created a magnetoelectric material that can directly stimulate neural tissue, potentially treating neurological disorders and nerve damage. The material generates an electric signal that neurons can detect, overcoming previous limitations.
A new NIH grant will help researchers better understand brain respiratory control and develop neuromodulation strategies to prevent Sudden Unexpected Death in Epilepsy (SUDEP). The goal is to identify optimal stimulation paradigms for breathing enhancement during a critical time window after seizures.
The study used transcranial photobiomodulation (tPBM) to stimulate the prefrontal cortex, a region involved in cognitive function. The results showed that tPBM modulated hemodynamic and metabolic activities in a wavelength- and site-specific manner.
Rice University engineers developed ultraflexible nanoelectrodes that can deliver high-resolution stimulation therapy with minimal scarring and degradation. The devices showed precise spatiotemporal stimulus control, enabling the development of new brain stimulation therapies for patients with impaired sensory or motor functions.
Joshua Chen, a Rice University doctoral alum, has won the prestigious Schmidt Science Fellowship to pursue research in synthetic biology and wirelessly programmable cell therapies for neurodegenerative diseases.
The FLASH system is a non-invasive and precise method to modulate hunger levels and treat metabolic and neurologic diseases. It utilizes electrodes on its surface to deliver electrical stimulation to stomach mucosal tissue, regulating the gut-brain axis.
Researchers at UTHealth Houston received $15 million in NIH BRAIN grants to study brain processes related to speech, epilepsy, and reading. A new minimally invasive device will be developed to record brain activity during speech, while another project aims to disrupt seizures using neuromodulation.
A study published in NEJM Evidence found that seizures can be predicted at least 35 minutes before onset in patients with temporal lobe epilepsy. This breakthrough discovery has significant implications for developing more effective therapies for this common seizure disorder, which affects over 50 million people globally.
NeuralTree is a closed-loop neuromodulation system-on-chip that can detect and classify biomarkers from real patient data and animal models of disease in-vivo, leading to high accuracy in symptom prediction. The system boasts 256 input channels, making it highly versatile and scalable.
A new algorithm developed by researchers at Charité improves motor symptoms comparable to standard of care treatment, increasing efficiency in deep brain stimulation for Parkinson's disease. The study suggests a promising result for imaging-based algorithms to simplify clinical practice and improve therapeutic outcomes.
A new geometrical-shaped magnet structure enables deep brain stimulation to reach 11 centimeters below the scalp, 1.67 times deeper than conventional methods. This improved design offers more focused stimulation and increased treatment potential for psychiatric diseases like major depression.
A new study has identified two distinct brain networks associated with risk and resilience in depression. The salience network is linked to increased depression symptoms, while the default mode network is linked to decreased depression symptoms. These findings may lead to new treatments for depression using neuromodulation therapies.
SpineX's proprietary SCiP TM device demonstrates unparalleled functional improvements in children with cerebral palsy, treating underlying neurological dysfunction and improving connectivity between the brain and spinal cord.
The Kessler Foundation has received significant funding to advance research on spinal cord injury, including studies on epidural stimulation and shockwave therapy for spasticity. The funding will also support the SCI Medicine Fellowship Program, which has trained approximately 50 specialists in spinal cord injury.
Researchers at the University of Minnesota have found that combining sound with electrical body stimulation activates the brain's somatosensory cortex, increasing its potential to treat chronic pain. This non-invasive technique has been tested on animals and is planned for human clinical trials in the near future.